Patent Assignment
Reel/Frame 038037/0424
Change of Name
Recorded: 2016-03-18
Pages: 7
Assignor
APTALIS PHARMA CANADA INC.
Executed: 2014-05-30
Assignee
APTALIS PHARMA CANADA ULC
4300 BANKERS HALL WEST, 888 - 3RD STREET S.W., CALGARY, T2P 5C5, CANADA
Covered Properties
(5)
Double Capsule for the Administration of Active Principles in Multiple Therapies
Patent:
6,350,468 →
Application:
09/581,721 →
Mesalamine Suppository
Method for Detecting Infectious Parvovirus in Pharmaceutical Preparations
Mesalamine Suppository
Mesalamine Suppository
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2009
From: GAUTHIER, CARL; DUMOULIN, YVES; POWELL, DAVID; MOREAU, HUGUES
To: AXCAN PHARMA INC.
Reel/Frame 023670/0156 →
Assignment of Assignor's Interest
Oct 14, 2013
From: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE
To: APTALIS PHARMA CANADA, INC.
Reel/Frame 031401/0475 →
Assignment of Assignor's Interest
Oct 14, 2013
From: TIJSSEN, PETER; SZELEI, JOZSEF; ZADORI, ZOLTAN
To: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 031401/0389 →
Release of Lien on Patents
Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA CANADA INC.
Reel/Frame 031494/0933 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Assignment of Assignor's Interest
Sep 23, 2019
From: APTALIS PHARMA CANADA ULC
To: APTALIS PHARMA US, INC.
Reel/Frame 050456/0734 →
Assignment of Assignor's Interest
Sep 23, 2019
From: APTALIS PHARMA US, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 050456/0816 →